Home > Share Market > Stocks > Vanta bioscience > Financial Statements > Key Financial Ratios

Vanta bioscience Financial Statements

Vanta bioscience Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 - -
Growth matrix (%)        
Revenue growth (29) -- -- --
Op profit growth (9.70) -- -- --
EBIT growth (17) -- -- --
Net profit growth (56) -- -- --
Profitability ratios (%)        
OPM 39.30 30.90 -- --
EBIT margin 27.20 23.30 -- --
Net profit margin 4.48 7.22 -- --
RoCE 5.18 -- -- --
RoNW 0.47 -- -- --
RoA 0.21 -- -- --
Per share ratios ()        
EPS 0.71 1.60 -- --
Dividend per share -- -- -- --
Cash EPS (1.30) (0.30) -- --
Book value per share 37.90 37.20 -- --
Valuation ratios        
P/E 230 56.90 -- --
P/CEPS (128) (343) -- --
P/B 4.30 2.45 -- --
EV/EBIDTA 34.20 16.70 -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (24) (25) -- --
Liquidity ratios        
Debtor days 61.80 -- -- --
Inventory days 432 -- -- --
Creditor days (178) -- -- --
Leverage ratios        
Interest coverage (1.30) (1.70) -- --
Net debt / equity 1.39 0.73 -- --
Net debt / op. profit 8.44 3.93 -- --
Cost breakup ()        
Material costs (8.20) (8.30) -- --
Employee costs (28) (36) -- --
Other costs (24) (25) -- --

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000